Eli Lilly And CO ELI LILLY ORD SH.../ US5324571083 /
23/05/2024 12:30:48 | Chg. - | Volume | Bid06:00:09 | Ask06:00:09 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
635.84CHF | - | 13,208 Turnover: 5,722.56 |
-Bid Size: - | -Ask Size: - | 733.2 bill.CHF | - | - |
GlobeNewswire
28/06
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
GlobeNewswire
27/06
Churchill Downs Incorporated Names Michael Lilly President of TwinSpires Horse Racing
GlobeNewswire
13/06
Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire
12/06
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First-Quarter Results
GlobeNewswire
12/06
US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire
11/06
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
GlobeNewswire
11/06
Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...
GlobeNewswire
10/06
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire
30/05
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024